Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Henk Joos Appointed Managing Director of FlandersBio

Published: Wednesday, January 15, 2014
Last Updated: Wednesday, January 15, 2014
Bookmark and Share
Henk’s objective is to maximize the valorization of the potential worldwide with FlandersBio.

The Board of Directors of FlandersBio has announced the appointment of Henk Joos as the new Managing Director of organization.

FlandersBio is the industrial networking organization for the life sciences sector in Flanders, a dynamic non-profit, fee-based organization with currently more than 280 members.

Henk (°1958, Roeselare) studied biology at the University of Ghent, where he obtained his PhD in 1984, after which he took the INSEAD Young Management Programme. Henk was active at Plant Genetic Systems (PGS) for a decade; first as a researcher and then as a business development manager.

After that he occupied various international management positions at, among others, AgrEvo, Aventis Cropscience, Bayer Cropscience, D1 oils and QUINVITA. Between 2004 and 2006 Henk was also a member of the FlandersBio’s Board of Directors. Therefore he was closely involved in the establishment of the organization.

“We are very pleased that Henk is joining the FlandersBio team as its Managing Director”, says Patrik De Haes, chairman of the Board of FlandersBio. “With his many years’ experience in the biotech sector, Henk can further develop FlandersBio into an integrated network that unites all actors. Several Flemish companies were at the outset of the industrialization of the various areas of biotechnology in Europe. The current Flemish biotech sector can therefore rely on a broad experience and an exceptional potential in this fast evolving and challenging business. Henk’s objective is to maximize the valorization of this potential worldwide with FlandersBio”.

Henk Joos is looking forward to his new position: “I consider becoming the Managing Director of FlandersBio a great honour, also at this historic moment in the existence of the organization, which is celebrating its 10th anniversary in 2014! FlandersBio has developed into a fascinating and extremely varied platform. I consider it my personal task to set up a very directional supportive policy for the members of FlandersBio. With the cluster of the FlandersBio member companies, Flanders has a unique flagship to further develop its knowledge economy internationally”.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biocartis Strengthens Management Team with CCO
Ulrik Cordes has joined the company as Chief Commercial Officer.
Thursday, September 05, 2013
KU Leuven and FIT Biotech Enter Into a Worldwide License Agreement
Collaboration agreement for the development of novel immunotherapeutics.
Tuesday, July 30, 2013
PathoGenetix and Applied Maths Sign Agreement
Both Companies to integrate RESOLUTION™ Microbial Genotyping System with BioNumerics™ software suite.
Thursday, June 27, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos